成都先衍生物技术有限公司 Reviews, Salaries and Jobs

Company Overview

Nature: 民营公司 Size: 少于50人 Founded: 4年
Industry: 制药/生物工程
Full name: 成都先衍生物技术有限公司。

Development Stage

Stage: A+轮。
Ranking: Ranked #26 in Chengdu新药研发公司 by popularity Ranked #54 in Chengdu生物制品公司 by popularity Ranked #73 in Chengdu生物医药公司 by popularity Ranked #128 in Chengdu医药公司 by popularity
Honors: 省科技型中小企业科技型中小企业 According to algorithm
Salary: 55% of positions earn 20-50K, In 2026 vs last yeardecreased by 17%.。Master's salary: ¥32.5K.
Recruiting: In 2026 vs 2025grew by 183%. Demand for highly educated talent: Master's: 7.
Requirement: Education: 本科 leads with 55%. Experience: 1-3年 leads with 30%.
Region: Distributed across 1 regions, 成都: 100%.

About the Company

[Summary] 医学研究和试验发展服务商

成都先衍生物技术有限公司成立于2022年，主要聚焦寡聚核酸新药领域，通过自主和合作开发针对代谢，心脑血管，慢性炎症和肿瘤免疫的新药，快速将寡聚核酸新药推向临床和商业化阶段。

Expand

Information is aggregated from the web and may not be exact. For reference only.

Information incorrect? Claim this company to edit

先衍生物 Financing History (4 rounds)

Manage

A+轮

Capital Market Favor

Latest Financing Round

Date: ?
Amount: 融资金额未公开
Investor: 高特佳投资

先衍生物 How Fast Is Hiring Growing? (17 open positions)

Manage

Growth Rate

2026 vs 2025

2025: Up 100%

先衍生物 Year-by-Year Hiring:

2024 3 jobs 2025 6 jobs 2026 17 jobs

Chengdu 16

先衍生物 Campus Recruitment & Advanced Degree Talent Demand

Master's 7

No.196

Recruitment Growth Ranking in Chengdu 򀀩

先衍生物 Latest Jobs

Note: How fast is hiring at 成都先衍生物技术有限公司 growing? 先衍生物2026: 17 openings (up 183%), 2025: 6 openings (up 100%), 2024: 3 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

先衍生物 Master's Degree Job Demand Analysis

(More)

Growth Rate

2026 vs 2025

2025: Up 50%

先衍生物 Master's Hiring by Year:

2024 2 jobs 2025 3 jobs 2026 ? *** 

* Hiring was generally low during 2020-2022 due to the pandemic

N/A

Master's Salary 򀀩

How fast is master's hiring at 成都先衍生物技术有限公司 growing? 先衍生物Master's recruitment over the years: 2025: 3 openings (up 50%), 2024: 2 openings.

先衍生物 — What Are the Salaries Like? (20 records)

Manage

先衍生物 Salary Overview

￥20-50K

55% of roles pay

salary range: 3K - 50K, 55% of roles pay ￥20-50K

5% 3-4.5K 5% 4.5-6K 10% 6-8K 10% 8-10K 10% 15-20K ***  ? 20-30K ***  ? 30-50K

Note: salary statistics are based on 20 salary records from the past year and depend on the job sample. For reference only.

先衍生物 Salary Ranking

By Category

生物/制药/化工/环保类￥25.7K  经营管理类  行政/后勤类  医疗卫生/美容保健类  客户服务类 

How is the salary at 成都先衍生物技术有限公司?先衍生物55% of positions earn 20-50K, Undergraduate salary: ¥。Chengdu salary ranking top 25，生物/制药/化工/环保类 average salary ¥25.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 先衍生物

(More)

Are salaries high at 成都先衍生物技术有限公司? We provide: 行政，人力，出纳，化学，ra，专利主管，临床试验助理，信息，副总，办公室主任，医学经理，研发主管，研究员，科学家，管理专员，运营，项目管理. Click to view detailed salary analysis by job.

先衍生物 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

先衍生物 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

生物/制药/化工/环保类
45% of total 45%
经营管理类
45% of total 45%
行政/后勤类
30% of total 30%
医疗卫生/美容保健类
20% of total 20%

Job Location

成都
100% of total 100%

Education

本科
55% of total 55%
硕士
40% of total 40%
大专
5% of total 5%

Experience

1-3年
30% of total 30%
3-5年
30% of total 30%
5-10年
25% of total 25%
不限
15% of total 15%

View Detailed Analysis

What does 成都先衍生物技术有限公司 require? Who is 先衍生物 hiring? 先衍生物 recruitment: 生物/制药/化工/环保类占比最多占45%，其次是经营管理类占45%. What education can get in at 先衍生物? 本科占比最多占55%，其次是硕士占40%. High education required at 先衍生物? 硕士占40%. Work experience required at 先衍生物? 1-3年占比最多占30%，其次是3-5年占30%. Where are the job locations at 先衍生物? 成都占比最多占100%. Based on job postings from the past year, for reference only.